The license will allow BIOPROCANN S.A. to become a cornerstone in medical cannabis production in Greece, Europe’s premium cultivation ground.
BIOPROCANN will be conducting business from a state-of-the-art growing facility of 48.000 m2 in Corinth, Greece. From inception to investment and implementation, the Company is leveraged to become a premium cannabis cultivator business brand with an international footprint.
Also See